Notificação de entrada na fase nacional - PCT
#1.3
04/04/2023
RPI 2726
Application data
Number
112023001615Type
Filing
Publication
PCT
US2021043791 The application was filed at the INPI on 07/29/2021. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 04/04/2023. We update with every new RPI gazette, published weekly.
Applicants
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
IE
Inventors
J. T. (pessoa física)
US
M. F. (pessoa física)
US
IPC Classification
Priority claims
US
63/070,449 · 08/26/2020
US
63/087,175 · 10/02/2020
US
63/092,211 · 10/15/2020
US
63/103,353 · 07/29/2020
US
63/129,362 · 12/22/2020
US
63/201,254 · 04/20/2021
Abstract
RATAMENTO PARA ENXAQUECA. A presente revelação fornece métodos para o tratamento de enxaqueca mediante a administração de atogepante ou um sal farmaceuticamente aceitável do mesmo.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
04/04/2023
RPI 2726
#1.1
02/07/2023
RPI 2718
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.